Review articleRole of the complement system in pulmonary disorders
References (61)
- et al.
C5a-C5ades arg-induced increase in blood pressure in the guinea pig: role of thromboxane
Immunopharmacology
(1990) - et al.
Effect of a topical corticosteroid on airway hyperresponsiveness and eosinophilic inflammation induced by trimellitic anhydride exposure in sensitized guinea pigs
J. Allergy Clin. Immunol.
(1993) - et al.
Contraction of guinea pig lung by synthetic oligopeptides related to human C3a
Immunopharmacology
(1984) - et al.
Anaphylatoxins: C3a and C5a
Adv. Immunol.
(1978) - et al.
The absence of detectable complement activation in aspirin-sensitive asthmatic patients during aspirin challenge
J. Allergy Clin. Immunol.
(1983) - et al.
Recombinant human C5a-induced bronchoconstriction in the guinea pig: a histamine independent mechanism
Pulmonary Pharmacology
(1990) - et al.
C3a-induced contraction of guinea pig lung parenchyma: role of cyclooxygenase metabolites
Immunopharmacology
(1983) - et al.
ELISA of complement C3a in bronchoalveolar lavage fluid
J. Immunological Methods
(1992) - et al.
Trimellitic anhydride-induced airway syndromes: clinical and immunologic studies
J. Allergy Clin. Immunol.
(1977) - et al.
Airway responses in vitro following C5a des arg-induced hyper-responsiveness in vivo in rabbits
Clinical and Experimental Pharmacology and Physiology
(1987)
Soluble Complement Receptor 1 (sCR1) prevents the increase in C3a during systemic anaphylaxis in the guinea pig
FASEB J.
(1995)
Plasma complement changes during bronchospasm provoked in asthmatic patients
Clin. Allergy
(1977)
Indomethacin inhibits the increased airway responsiveness to histamine following inhalation of C5a des arg in rabbits
Agents and Actions
(1986)
Immunological aspects of allergic asthma
Annu. Rev. lmmunol.
(1994)
Actions of anaphylatoxins on circulation and respiration of the guinea pig
Int. Archs. Allergy Appl. Immun.
(1967)
The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement
J. Exp. Med.
(1968)
C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation
J. Exp. Med.
(1995)
Cardiac anaphylaxis-complement activation as an amplification system
Circ. Res.
(1989)
Recombinant human C5a-induced bronchoconstriction in the guinea pig: inhibition by an H1 antagonist after depletion of circulating granulocytes and platelets
J. Pharmacol. Exp. Ther.
(1991)
Trimellitic anhydride-induced allergic response in the lung: Role of the complement system in cellular changes
J. Pharmacol. Exp. Ther.
(1995)
Weitere Untersuchungen uber Eiweissanaphylaxie. IV
Z. ImmunForsch. Exp. Ther.
(1910)
Amino acid sequence of guinea pig C3a anaphylatoxin
Protein Seq. Data Anal.
(1988)
Changes in arteriovenous complement activity induced by inhalation challenge
Am. Rev. Respir. Dis.
(1973)
Specific immunological and bronchopulmonary responses following intradermal sensitization to free trimellitic anhydride in guinea pigs
Clinical and Experimental Allergy
(1991)
Bronchial hyperreactivity after inhalation of trimellitic anhydride dust in guinea pigs after intradermal sensitization to free hapten
Am. Rev. Respir. Dis.
(1992)
Involvement of inflammatory mediators in the airway responses to trimellitic anhydride in sensitized guinea-pigs
Br. J. Pharmacol.
(1992)
Acute immune complex disease in rabbits
Cellular and molecular mechanisms involved in the regulation of eosinophil trafficking in vivo
Medicinal Research Reviews
(1996)
The C5a chemoattractant receptor mediates mucosal defence to infection
Nature
(1996)
Changes of serum complement and eosinophil count in antigen induced bronchospasm
Ann. Allergy
(1978)
Cited by (21)
Complement
2021, Encyclopedia of Respiratory Medicine, Second EditionAnaphylatoxins coordinate innate and adaptive immune responses in allergic asthma
2013, Seminars in ImmunologyCitation Excerpt :The role of the anaphylatoxins (AT) C3a and C5a as pro-inflammatory effector molecules of the complement system is well appreciated. As such, they have long been considered as drivers of bronchoconstriction and airway inflammation during the effector phase of allergic asthma [1]. More than a decade has passed since the first description that C5 can protect from the development of allergic asthma in a mouse model [2].
MEN16132, a kinin B<inf>2</inf> receptor antagonist, prevents the endogenous bradykinin effects in guinea-pig airways
2008, European Journal of PharmacologyImmune complex disease (Serum Sickness)
2007, xPharm: The Comprehensive Pharmacology ReferenceCOMPLEMENT
2006, Encyclopedia of Respiratory Medicine: Volume 1-4Complement
2006, Encyclopedia of Respiratory Medicine, Four-Volume Set
- ∗
Tel.: + 1-218-726-8950; fax: + 1-218-726-6235
Copyright © 1997 Published by Elsevier B.V.